Literature DB >> 27190811

Clinico-Histopathological Spectrum of Infectious Granulomatous Dermatoses in Western India- A Representative Study from Mumbai.

Sumit Grover1, Shubhangi Vinayak Agale2, Grace F D'Costa3, Arvind G Valand4, Vikram Kumar Gupta5.   

Abstract

INTRODUCTION: Infectious Granulomatous Dermatoses (IGDS) have various aetiological factors with a considerable overlap in the histopathological and clinical features, thus posing a diagnostic dilemma for dermatologists and pathologists. AIM: We aimed at determining the histopathological profile of IGDS correlating it with clinical features with an attempt to find the aetiology.
MATERIALS AND METHODS: In a cross-sectional study conducted in a tertiary referral center of Mumbai over two years, out of 1872 skin biopsies received, 239 histopathologically diagnosed cases of IGDS were studied for histopathological features of granuloma. A clinico-histopathological correlation was attempted. Chi-square test was used for comparison of proportions of different groups.
RESULTS: Leprosy (211 cases) and tuberculosis (28 cases) were the commonest histopathologically diagnosed IGDS. Leprosy spectrum included BT (30.33% cases), followed by TT (21.32%), BL and LL and 21.79% cases of lepra reactions. Skin TB biopsies on histopathology showed lupus vulgaris (53.85% cases), scrofuloderma (15.38%), TBVC and papulonecrotic tuberculid (11.54% each). In leprosy maximum clinico-pathological agreement was seen at tuberculoid pole (TT 72.7% and BT 56.6%). Among tuberculosis cases, scrofuloderma (100%) and lupus vulgaris (53.8%) showed maximum agreement.
CONCLUSION: Leprosy and skin TB are the commonest IGDS in Mumbai region though difficult to diagnose and subcategorize with certainty during initial stages. Histopathology plays the important role to elucidate the dilemma. This being a single center study, more such studies with a larger sample size are recommended to get more elaborate data and regional prevalence of these IGDS for a better overall approach to prevention, treatment and control.

Entities:  

Keywords:  Leprosy; Lupus vulgaris; Scrofuloderma; Tuberculosis

Year:  2016        PMID: 27190811      PMCID: PMC4866109          DOI: 10.7860/JCDR/2016/16459.7568

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Significance of histopathological classification in leprosy.

Authors:  N S Nadkarni; V L Rege
Journal:  Indian J Lepr       Date:  1999 Jul-Sep

2.  Clinical and histopathological correlation in leprosy.

Authors:  G Kalla; A Salodkar; D Kachhawa
Journal:  Int J Lepr Other Mycobact Dis       Date:  2000-06

3.  Clinico-epidemiological trends of leprosy in Himachal Pradesh: a five year study.

Authors:  N Jindal; V Shanker; G R Tegta; M Gupta; G K Verma
Journal:  Indian J Lepr       Date:  2009 Oct-Dec

4.  Histopathological correlation of skin biopsies in leprosy.

Authors:  B N Moorthy; P Kumar; K R Chatura; H R Chandrasekhar; P K Basavaraja
Journal:  Indian J Dermatol Venereol Leprol       Date:  2001 Nov-Dec       Impact factor: 2.545

5.  Clinicohistopathological correlation of leprosy.

Authors:  Amrish N Pandya; Hemali J Tailor
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Mar-Apr       Impact factor: 2.545

6.  Limitations of clinico-histopathological correlation of skin biopsies in leprosy.

Authors:  R Jha; S Karki
Journal:  J Nepal Health Res Counc       Date:  2010-04

7.  A clinico-pathological study of macular lesions in leprosy.

Authors:  P K Kar; P N Arora; C V Ramasastry; S K Sayal; R S Dhaka
Journal:  Indian J Lepr       Date:  1994 Oct-Dec

8.  Diversities in clinical and histopathological classification of leprosy.

Authors:  V P Jerath; S R Desai
Journal:  Lepr India       Date:  1982-01

9.  Histopathology of skin lesions in leprosy.

Authors: 
Journal:  Malays J Pathol       Date:  1980-08       Impact factor: 0.656

10.  Clinicohistopathological correlation in leprosy.

Authors:  M C Mathur; R B K Ghimire; P Shrestha; S K Kedia
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2011 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.